Brief: APONTIS PHARMA: Start Study Published In Scientific Journal

Apontis Pharma AG

16/03/2022 06:34

March 16 (Reuters) - APONTIS PHARMA AG  APPHG.DE :
    * START STUDY PUBLISHED IN SCIENTIFIC JOURNAL - LOWER
INCIDENCE OF
CARDIOVASCULAR EVENTS WITH SINGLE PILL THERAPY
    * SINGLE-PILL THERAPY APPROACH SHOULD GENERALLY BE PREFERRED
FOR
CARDIOVASCULAR PATIENTS ON LONG-TERM THERAPY TO IMPROVE
PROGNOSIS OF THESE PATIENTS.
    * DATA FROM 59,336 PATIENTS WERE INCLUDED IN EVALUATION

Source text for Eikon:  ID:nEQ4M5dLGa 
Further company coverage:  APPHG.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))